series-c-plus
Stage
1
Investors
About
biomodal develops multiomics sequencing technologies that simultaneously profile genetic and epigenetic DNA modifications from low input samples, enabling deeper biological insights for applications such as cancer research and liquid biopsy.
Explore biomodal's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.